The decreased serum level of SMAC correlated negatively with both the progressive cancer stage and early recurrence of tumors in these patients, indicating that serum levels of SMAC may be a prognostic biomarker for bladder cancer [88]. The gene discussed is DIABLO; the disease is cancer.